1. A Phase 2 Proof‐of‐Concept, Randomized, Placebo‐Controlled Trial of CX‐8998 in Essential Tremor. Issue 8 (25th March 2021) Authors: Papapetropoulos, Spyros; Lee, Margaret S.; Versavel, Stacey; Newbold, Evan; Jinnah, Hyder A.; Pahwa, Rajesh; Lyons, Kelly E.; Elble, Rodger; Ondo, William; Zesiewicz, Theresa; Hedera, Peter; Handforth, Adrian; Elder, Jenna; Versavel, Mark Journal: Movement disorders Issue: Volume 36:Issue 8(2021) Page Start: 1944 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of the Pharmacokinetic Interaction Between the Voltage‐ and Use‐Dependent Nav1.7 Channel Blocker Vixotrigine and Carbamazepine in Healthy Volunteers. Issue 1 (24th October 2019) Authors: Dunbar, Joi; Versavel, Mark; Zhao, Yuan; Tate, Simon; Morisset, Valerie; Giblin, Gerard M. P.; Palmer, Joanne; Tidemann‐Miller, Beth; Naik, Himanshu Journal: Clinical pharmacology in drug development Issue: Volume 9:Issue 1(2020) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Exploratory Biomarker Study of the Triple Reuptake Inhibitor SEP‐432 Compared to the Dual Reuptake Inhibitor Duloxetine in Healthy Normal Subjects. (5th February 2016) Authors: Sramek, John J.; Hardy, Larry W.; Bieck, Peter; Zamora, Cynthia; Versavel, Mark; Kharidia, Jahnavi; Grinnell, Todd; Chen, Yu‐Luan; Sullivan, Michael; Ding, Hong; Cutler, Neal R. Journal: CNS neuroscience & therapeutics Issue: Volume 22:Number 5(2016) Page Start: 404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P2‐012: Phase 1 Development of ALZ‐801, a Novel Beta Amyloid Anti‐Aggregation Prodrug of Tramiprosate with Improved Drug Properties, Supporting Bridging to The Phase 3 Program. (1st July 2016) Authors: Hey, John; Abushakra, Susan; Power, Aidan; Yu, Jeremy; Versavel, Mark; Tolar, Martin Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 12 Page Start: P613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pain intensity rating training: results from an exploratory study of the ACTTION PROTECCT system. Issue 5 (May 2016) Authors: Smith, Shannon M.; Amtmann, Dagmar; Askew, Robert L.; Gewandter, Jennifer S.; Hunsinger, Matthew; Jensen, Mark P.; McDermott, Michael P.; Patel, Kushang V.; Williams, Mark; Bacci, Elizabeth D.; Burke, Laurie B.; Chambers, Christine T.; Cooper, Stephen A.; Cowan, Penney; Desjardins, Paul; Etropols... Journal: Pain Issue: Volume 157:Issue 5(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations. Issue 9 (September 2016) Authors: Edwards, Robert R.; Dworkin, Robert H.; Turk, Dennis C.; Angst, Martin S.; Dionne, Raymond; Freeman, Roy; Hansson, Per; Haroutounian, Simon; Arendt-Nielsen, Lars; Attal, Nadine; Baron, Ralf; Brell, Joanna; Bujanover, Shay; Burke, Laurie B.; Carr, Daniel; Chappell, Amy S.; Cowan, Penney; Etropolsk... Journal: Pain Issue: Volume 157:Issue 9(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of Vixotrigine in Healthy Volunteers. Issue 4 (13th December 2020) Authors: Naik, Himanshu; Steiner, Deb J.; Versavel, Mark; Palmer, Joanne; Fong, Regan Journal: Clinical and translational science Issue: Volume 14:Issue 4(2021) Page Start: 1272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗